Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:36 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: | NSE:

Sakar Healthcare Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹327.20Overvalued by 36.59%vs CMP ₹516.00

P/E (45.5) × ROE (6.5%) × BV (₹136.00) × DY (2.00%)

₹182.36Overvalued by 64.66%vs CMP ₹516.00
MoS: -183% (Negative)Confidence: 68/100 (Moderate)Models: All 9: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹343.6322%Over (-33.4%)
Graham NumberEarnings₹186.5316%Over (-63.9%)
Earnings PowerEarnings₹18.8413%Over (-96.3%)
DCFCash Flow₹120.1513%Over (-76.7%)
Net Asset ValueAssets₹136.317%Over (-73.6%)
EV/EBITDAEnterprise₹287.029%Over (-44.4%)
Earnings YieldEarnings₹113.707%Over (-78%)
ROCE CapitalReturns₹152.817%Over (-70.4%)
Revenue MultipleRevenue₹80.085%Over (-84.5%)
Consensus (9 models)₹182.36100%Overvalued
Key Drivers: Wide model spread (₹19–₹344) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 5.0%

*Investments are subject to market risks

Investment Snapshot

64
Sakar Healthcare Ltd scores 64/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health61/100 · Moderate
ROCE 8.5% AverageROE 6.5% AverageD/E 0.40 ModerateInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
FII holding stable No changePromoter holding at 52.9% Stable
Earnings Quality65/100 · Strong
OPM expanding (24% → 27%) Improving
Quarterly Momentum90/100 · Strong
Revenue (4Q): +36% YoY AcceleratingProfit (4Q): +73% YoY Strong
Industry Rank45/100 · Moderate
P/E 45.5 vs industry 75.2 Cheaper than peersROCE 8.5% vs industry 14.7% Below peersROE 6.5% vs industry 13.9% Below peers3Y sales CAGR: 12% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:36 am

Market Cap 1,147 Cr.
Current Price 516
Intrinsic Value₹182.36
High / Low 578/220
Stock P/E45.5
Book Value 136
Dividend Yield0.00 %
ROCE8.54 %
ROE6.48 %
Face Value 10.0
PEG Ratio9.06

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Sakar Healthcare Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Sakar Healthcare Ltd 1,147 Cr. 516 578/22045.5 1360.00 %8.54 %6.48 % 10.0
Shalby Ltd 1,507 Cr. 140 275/126187 92.80.00 %6.12 %0.62 % 10.0
Aashka Hospitals Ltd 140 Cr. 60.0 108/59.0123 42.50.00 %4.07 %2.39 % 10.0
Artemis Medicare Services Ltd 3,528 Cr. 223 306/20335.5 56.00.20 %14.9 %12.9 % 1.00
Indraprastha Medical Corporation Ltd 3,664 Cr. 400 641/32220.0 71.81.13 %39.1 %30.0 % 10.0
Industry Average26,819.31 Cr611.5975.1783.710.36%14.71%13.91%9.04

All Competitor Stocks of Sakar Healthcare Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 33413934374341434350535870
Expenses 25333025283230313235404652
Operating Profit 989991111121216131119
OPM % 26%19%23%27%24%25%26%27%27%31%24%20%26%
Other Income 2221010000011
Interest 2222221214222
Depreciation 4454455555666
Profit before tax 54443555565511
Tax % 13%-1%28%13%31%35%49%6%17%8%13%15%6%
Net Profit 44342325565510
EPS in Rs 2.152.061.491.700.951.431.112.212.062.622.102.044.61

Last Updated: March 3, 2026, 3:00 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 4:16 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 3035414453688395128133153178231
Expenses 222733344051637299100115128172
Operating Profit 88810131720232933385058
OPM % 26%22%20%23%24%25%24%24%23%25%25%28%25%
Other Income 0001012125312
Interest 43333222368910
Depreciation 223346781015182123
Profit before tax 22356912131917162228
Tax % 13%24%22%30%38%28%21%19%20%24%27%19%
Net Profit 22234710111513121825
EPS in Rs 2.192.302.783.083.124.476.436.848.906.705.377.9711.37
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)0.00%0.00%50.00%33.33%75.00%42.86%10.00%36.36%-13.33%-7.69%50.00%
Change in YoY Net Profit Growth (%)0.00%0.00%50.00%-16.67%41.67%-32.14%-32.86%26.36%-49.70%5.64%57.69%

Sakar Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:18%
5 Years:16%
3 Years:11%
TTM:22%
Compounded Profit Growth
10 Years:25%
5 Years:13%
3 Years:5%
TTM:76%
Stock Price CAGR
10 Years:%
5 Years:36%
3 Years:13%
1 Year:6%
Return on Equity
10 Years:9%
5 Years:8%
3 Years:7%
Last Year:6%

Last Updated: September 5, 2025, 1:15 pm

Balance Sheet

Last Updated: January 7, 2026, 4:20 pm

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 88811121515161719222222
Reserves 67112539576683110154241264281
Borrowings 242522241111174393119798672
Other Liabilities 14111011181517374744474373
Total Liabilities 525051718197115178268336389415449
Fixed Assets 3836374953646669205267314309325
CWIP 00000913491601717
Investments 0000000073000
Other Assets 141414222825366055607490107
Total Assets 525051718197115178268336389415449

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 9492516191536332434
Cash from Investing Activity + -3-1-4-14-8-25-22-47-90-74-52-31
Cash from Financing Activity + -6-3-613-139332554127-3
Net Cash Flow -01-10-160-0-0-000-0
Free Cash Flow 645-13-4-9-4-32-62-49-352
CFO/OP 115%60%117%30%51%104%110%67%121%113%72%73%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-16.00-17.00-14.00-14.002.006.003.00-20.00-64.00-86.00-41.00-36.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 282126447451364840605063
Inventory Days 1901421071145170921126976121193
Days Payable 9720665157414614114912912093
Cash Conversion Cycle 1201436710768808319-39751163
Working Capital Days -82710679831312-11-62952
ROCE %15%14%14%15%14%16%16%13%12%9%7%9%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 60.72%60.72%54.15%53.15%53.15%53.15%53.15%53.58%53.58%52.86%52.86%52.86%
FIIs 15.74%15.74%14.03%13.76%13.52%13.52%13.42%13.58%13.61%13.41%13.31%13.05%
DIIs 0.00%0.00%10.82%10.62%10.62%10.62%10.62%10.88%10.97%11.25%11.43%11.36%
Public 23.54%23.54%21.00%22.47%22.71%22.71%22.80%21.96%21.85%22.48%22.41%22.73%
No. of Shareholders 6,3226,0567,2997,0017,3867,3137,8678,5988,6088,1157,5657,069

Shareholding Pattern Chart

No. of Shareholders

Sakar Healthcare Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 7.975.636.758.736.84
Diluted EPS (Rs.) 7.955.636.758.736.84
Cash EPS (Rs.) 17.4913.6614.5714.5212.00
Book Value[Excl.RevalReserv]/Share (Rs.) 130.06120.6191.0474.4663.04
Book Value[Incl.RevalReserv]/Share (Rs.) 130.06120.6191.0474.4663.04
Revenue From Operations / Share (Rs.) 80.9070.5170.0474.9160.66
PBDIT / Share (Rs.) 23.2319.1019.8618.4015.22
PBIT / Share (Rs.) 13.7210.8011.9912.7510.06
PBT / Share (Rs.) 9.817.318.8711.068.47
Net Profit / Share (Rs.) 7.975.376.708.876.84
NP After MI And SOA / Share (Rs.) 7.975.376.708.876.84
PBDIT Margin (%) 28.7127.0828.3524.5625.09
PBIT Margin (%) 16.9515.3117.1117.0216.58
PBT Margin (%) 12.1210.3612.6514.7613.96
Net Profit Margin (%) 9.857.619.5611.8311.27
NP After MI And SOA Margin (%) 9.857.619.5611.8311.27
Return on Networth / Equity (%) 6.134.447.3611.9010.85
Return on Capital Employeed (%) 8.557.128.109.8710.87
Return On Assets (%) 4.213.003.795.666.00
Long Term Debt / Equity (X) 0.180.200.560.660.39
Total Debt / Equity (X) 0.260.260.640.700.40
Asset Turnover Ratio (%) 0.440.420.440.570.64
Current Ratio (X) 1.401.211.031.071.01
Quick Ratio (X) 0.710.740.740.760.54
Inventory Turnover Ratio (X) 4.980.000.000.000.00
Interest Coverage Ratio (X) 5.985.476.3610.879.58
Interest Coverage Ratio (Post Tax) (X) 3.062.543.156.245.30
Enterprise Value (Cr.) 539.37869.42493.09320.85216.70
EV / Net Operating Revenue (X) 3.045.673.702.502.29
EV / EBITDA (X) 10.5820.9313.0410.199.12
MarketCap / Net Operating Revenue (X) 2.625.222.861.801.86
Price / BV (X) 1.633.052.201.811.79
Price / Net Operating Revenue (X) 2.625.222.861.801.86
EarningsYield 0.030.010.030.060.06

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Sakar Healthcare Ltd. is a Public Limited Listed company incorporated on 26/03/2004 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ2004PLC043861 and registration number is 043861. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 177.58 Cr. and Equity Capital is Rs. 21.95 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesBlock No. 10/13, Village: Changodar, Ahmedabad District Gujarat 382213Contact not found
Management
NamePosition Held
Mr. Sanjay S ShahChairman & Managing Director
Mr. Aarsh S ShahJoint Managing Director
Mr. Sunil MaratheWhole Time Director - Technical
Ms. Vishalakshi ChandramouliNon Executive Director
Ms. Rita S ShahNon Executive Director
Mr. Hemendra C ShahIndependent Director
Mr. Shailesh B PatelIndependent Director
Mr. Prashant C SrivastavIndependent Director
Mr. Jignesh ParikhIndependent Director
Mrs. Khyati ShahIndependent Director
Ms. Megha SamdaniIndependent Director
Ms. Reeya KothariIndependent Director
Ms. Hiral PatelIndependent Director

FAQ

What is the intrinsic value of Sakar Healthcare Ltd and is it undervalued?

As of 09 April 2026, Sakar Healthcare Ltd's intrinsic value is ₹182.36, which is 64.66% lower than the current market price of ₹516.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (6.48 %), book value (₹136), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Sakar Healthcare Ltd?

Sakar Healthcare Ltd is trading at ₹516.00 as of 09 April 2026, with a FY2026-2027 high of ₹578 and low of ₹220. The stock is currently near its 52-week high. Market cap stands at ₹1,147 Cr..

How does Sakar Healthcare Ltd's P/E ratio compare to its industry?

Sakar Healthcare Ltd has a P/E ratio of 45.5, which is below the industry average of 75.17. This is broadly in line with or below the industry average.

Is Sakar Healthcare Ltd financially healthy?

Key indicators for Sakar Healthcare Ltd: ROCE of 8.54 % is on the lower side compared to the industry average of 14.71%; ROE of 6.48 % is below ideal levels (industry average: 13.91%). Dividend yield is 0.00 %.

Is Sakar Healthcare Ltd profitable and how is the profit trend?

Sakar Healthcare Ltd reported a net profit of ₹18 Cr in Mar 2025 on revenue of ₹178 Cr. Compared to ₹15 Cr in Mar 2022, the net profit shows an improving trend.

Does Sakar Healthcare Ltd pay dividends?

Sakar Healthcare Ltd has a dividend yield of 0.00 % at the current price of ₹516.00. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Sakar Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports